| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |